Epilepsy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Description
Epilepsy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Epilepsy - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Epilepsy (Central Nervous System) pipeline landscape.
Epilepsy is a neurological disorder characterized by the transmission of abnormal signals produced by a group of neurons in the brain which causes seizures. This leads to brief disruptions of the senses and short periods of unconsciousness or convulsions. Symptoms of epilepsy are repeated seizures, weakness, and anxiety, loss of consciousness and contraction, or jerking, of body muscles. Main causes of epilepsy include low oxygen during birth, head injuries that occur during birth or from accidents during youth or adulthood, brain tumors, genetic conditions that result in brain injury, such as tuberous sclerosis, infections such as meningitis or encephalitis, and stroke or any other type of damage to the brain.
Report Highlights
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Epilepsy - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides comprehensive information on the therapeutics under development for Epilepsy (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Epilepsy (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Epilepsy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 3, 2, 14, 28, 27, 4, 141, 41 and 6 respectively. Similarly, the Universities portfolio in Phase I, Preclinical and Discovery stages comprises 2, 23 and 3 molecules, respectively.
Epilepsy (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note:Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
Scope
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Epilepsy - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Epilepsy (Central Nervous System) pipeline landscape.
Epilepsy is a neurological disorder characterized by the transmission of abnormal signals produced by a group of neurons in the brain which causes seizures. This leads to brief disruptions of the senses and short periods of unconsciousness or convulsions. Symptoms of epilepsy are repeated seizures, weakness, and anxiety, loss of consciousness and contraction, or jerking, of body muscles. Main causes of epilepsy include low oxygen during birth, head injuries that occur during birth or from accidents during youth or adulthood, brain tumors, genetic conditions that result in brain injury, such as tuberous sclerosis, infections such as meningitis or encephalitis, and stroke or any other type of damage to the brain.
Report Highlights
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Epilepsy - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides comprehensive information on the therapeutics under development for Epilepsy (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Epilepsy (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Epilepsy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 3, 2, 14, 28, 27, 4, 141, 41 and 6 respectively. Similarly, the Universities portfolio in Phase I, Preclinical and Discovery stages comprises 2, 23 and 3 molecules, respectively.
Epilepsy (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note:Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Epilepsy (Central Nervous System).
- The pipeline guide reviews pipeline therapeutics for Epilepsy (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Epilepsy (Central Nervous System) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Epilepsy (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Epilepsy (Central Nervous System)
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Epilepsy (Central Nervous System).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Epilepsy (Central Nervous System) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Companies Mentioned
Companies Mentioned
a:head Bio AG
Aadi Bioscience Inc
Accure Therapeutics SL
Advanced Neural Dynamics Inc
Advicenne SA
Aequus Pharmaceuticals Inc
AfaSci Inc
Affectis Pharmaceuticals AG
AgoneX Biopharmaceuticals Inc
Altamira Therapeutics Ltd
AMO Pharma Ltd
Anavex Life Sciences Corp
Aphios Corp
Apteeus SAS
Aquestive Therapeutics Inc
Arovella Therapeutics Ltd
Aucta Pharmaceuticals LLC
Aurum Biosciences Ltd
Avicanna Inc
Azurity Pharmaceuticals Inc
B&A Therapeutics
Baergic Bio Inc
BCWorld Pharm Co Ltd
Bio-Pharm Solutions Co Ltd
Bioasis Technologies Inc
Bioinnotis
Biom Therapeutics LLC
Biorchestra Co Ltd
Biovista Inc
Bloom Science Inc
Bright Minds Biosciences Inc
Bristol-Myers Squibb Co
CAMP4 Therapeutics Corp
Cann Pharmaceutical Australia Ltd
Cavion LLC
Celavie Biosciences LLC
Cellix Bio Pvt Ltd
Cerebral Therapeutics Inc
Cerecin Pte Ltd
Cerevel Therapeutics Holdings Inc
Coda Biotherapeutics Inc
Corestem Inc
Corlieve Therapeutics SAS
Crossject SA
CSL Ltd
Cure Pharmaceutical Holding Corp
CuroNZ Ltd
CURx Pharmaceuticals Inc
Cypralis Ltd
Eisai Co Ltd
Eliem Therapeutics Inc
Encoded Therapeutics Inc
Engrail Therapeutics Inc
Epalex Corp
EpyGenix Therapeutics Inc
Equilibre Biopharmaceuticals Corp
ES Therapeutics LLC
Eton Pharmaceuticals Inc
Ferring Pharmaceuticals Inc
GABA Therapeutics Inc
GAOMA Therapeutics
Gene Therapy Research Institution Co Ltd
GenEp Inc
Genochem SAS
Genus Lifesciences Inc
Guangzhou Cellprotek Pharmaceutical Co Ltd
H. Lundbeck AS
Harbin Pharmaceutical Group Co Ltd
Herophilus
ImmunoChem Therapeutics LLC
InteRNA Technologies BV
Ionis Pharmaceuticals Inc
Iproteos SL
iQure Pharma Inc
Jazz Pharmaceuticals Plc
JC Pharma Inc
Johnson & Johnson
Ketogen Inc
Klaria Pharma Holding AB
Knopp Biosciences LLC
LATITUDE Pharmaceuticals Inc
Lead Discovery Center GmbH
Lexaria Bioscience Corp
LifeSplice Pharma LLC
Lipocine Inc
Longboard Pharmaceuticals Inc
Luminus Biosciences Inc
Marinus Pharmaceuticals Inc
Medicure Inc
Mediphage Bioceuticals Inc
Medlab Clinical Ltd
Mercaptor Discoveries Inc
Metys Pharmaceuticals AG
MGC Pharmaceuticals Ltd
Mucodel Pharma LLC
MyMD Pharmaceuticals, Inc
MyX Therapeutics Inc
Nasus Pharma Ltd
Navega Therapeutics Inc
Navitor Pharmaceuticals Inc
Neonc Technologies Inc
NeuCyte Inc
NeuExcell Therapeutics Inc
NeurAegis Inc
Neuraxpharm France SAS
Neurelis Inc
NeuroAdjuvants Inc
Neurocrine Biosciences Inc
Neuroene Therapeutics LLC
Neurona Therapeutics Inc
New Amsterdam Sciences Inc
Nissan Chemical Corp
Noema Pharma AG
NoNO Inc
NuBioPharma LLC
OB Pharmaceuticals
OMass Therapeutics Limited
Oncocross Co Ltd
Otsuka Pharmaceutical Co Ltd
Ovid Therapeutics Inc
OWP Pharmaceuticals Inc
Panaxia Pharmaceutical Industries Ltd
Pfizer Inc
PharmaTher Holdings Ltd
PharmatrophiX Inc
PIQUR Therapeutics AG
Praxis Precision Medicines Inc
Primetime Life Sciences LLC
Promius Pharma LLC
Proniras Corp
Protheragen Inc
Proveca Ltd
PTC Therapeutics Inc
Puretech Health Plc
Q-State Biosciences Inc
Reata Pharmaceuticals Inc
reMYND NV
RespireRx Pharmaceuticals Inc
RogCon Inc
Sage Therapeutics Inc
Saniona AB
Scientus Pharma Inc
SciSparc Ltd
Serina Therapeutics Inc
Shackelford Pharma Inc
Shanghai Lvdao Pharmaceutical Technology Co Ltd
Shanghai Zhimeng Biopharma Inc
Simcere Pharmaceutical Group Ltd
SK Biopharmaceuticals Co Ltd
SK Chemicals Co Ltd
Skye Bioscience Inc
SoVarGen Co Ltd
Spark Therapeutics Inc
Stoke Therapeutics Inc
StrideBio Inc
Sumitomo Dainippon Pharma Co Ltd
Sun Pharma Advanced Research Company Ltd
Supernus Pharmaceuticals Inc
Sustained Nano Systems LLC
Taho Pharmaceuticals Ltd
Takeda Pharmaceutical Co Ltd
Tavanta Therapeutics Inc
Taysha Gene Therapies Inc
Techfields Pharma Co Ltd
Tevard Biosciences LLC
The Cell Factory BVBA
Trevena Inc
UCB SA
Ultragenyx Pharmaceutical Inc
Viatris Inc
Virpax Pharmaceuticals Inc
VistaGen Therapeutics Inc
Vitality Biopharma Inc
Vyripharm Biopharmaceuticals
Whan In Pharm Co Ltd
Xenon Pharmaceuticals Inc
Xeris Biopharma Holdings Inc
XPhyto Therapeutics Corp
XWPharma Ltd
Zhejiang Conba Pharmaceutical Co Ltd
Zogenix Inc
Zynerba Pharmaceuticals Inc
Companies Mentioned
a:head Bio AG
Aadi Bioscience Inc
Accure Therapeutics SL
Advanced Neural Dynamics Inc
Advicenne SA
Aequus Pharmaceuticals Inc
AfaSci Inc
Affectis Pharmaceuticals AG
AgoneX Biopharmaceuticals Inc
Altamira Therapeutics Ltd
AMO Pharma Ltd
Anavex Life Sciences Corp
Aphios Corp
Apteeus SAS
Aquestive Therapeutics Inc
Arovella Therapeutics Ltd
Aucta Pharmaceuticals LLC
Aurum Biosciences Ltd
Avicanna Inc
Azurity Pharmaceuticals Inc
B&A Therapeutics
Baergic Bio Inc
BCWorld Pharm Co Ltd
Bio-Pharm Solutions Co Ltd
Bioasis Technologies Inc
Bioinnotis
Biom Therapeutics LLC
Biorchestra Co Ltd
Biovista Inc
Bloom Science Inc
Bright Minds Biosciences Inc
Bristol-Myers Squibb Co
CAMP4 Therapeutics Corp
Cann Pharmaceutical Australia Ltd
Cavion LLC
Celavie Biosciences LLC
Cellix Bio Pvt Ltd
Cerebral Therapeutics Inc
Cerecin Pte Ltd
Cerevel Therapeutics Holdings Inc
Coda Biotherapeutics Inc
Corestem Inc
Corlieve Therapeutics SAS
Crossject SA
CSL Ltd
Cure Pharmaceutical Holding Corp
CuroNZ Ltd
CURx Pharmaceuticals Inc
Cypralis Ltd
Eisai Co Ltd
Eliem Therapeutics Inc
Encoded Therapeutics Inc
Engrail Therapeutics Inc
Epalex Corp
EpyGenix Therapeutics Inc
Equilibre Biopharmaceuticals Corp
ES Therapeutics LLC
Eton Pharmaceuticals Inc
Ferring Pharmaceuticals Inc
GABA Therapeutics Inc
GAOMA Therapeutics
Gene Therapy Research Institution Co Ltd
GenEp Inc
Genochem SAS
Genus Lifesciences Inc
Guangzhou Cellprotek Pharmaceutical Co Ltd
H. Lundbeck AS
Harbin Pharmaceutical Group Co Ltd
Herophilus
ImmunoChem Therapeutics LLC
InteRNA Technologies BV
Ionis Pharmaceuticals Inc
Iproteos SL
iQure Pharma Inc
Jazz Pharmaceuticals Plc
JC Pharma Inc
Johnson & Johnson
Ketogen Inc
Klaria Pharma Holding AB
Knopp Biosciences LLC
LATITUDE Pharmaceuticals Inc
Lead Discovery Center GmbH
Lexaria Bioscience Corp
LifeSplice Pharma LLC
Lipocine Inc
Longboard Pharmaceuticals Inc
Luminus Biosciences Inc
Marinus Pharmaceuticals Inc
Medicure Inc
Mediphage Bioceuticals Inc
Medlab Clinical Ltd
Mercaptor Discoveries Inc
Metys Pharmaceuticals AG
MGC Pharmaceuticals Ltd
Mucodel Pharma LLC
MyMD Pharmaceuticals, Inc
MyX Therapeutics Inc
Nasus Pharma Ltd
Navega Therapeutics Inc
Navitor Pharmaceuticals Inc
Neonc Technologies Inc
NeuCyte Inc
NeuExcell Therapeutics Inc
NeurAegis Inc
Neuraxpharm France SAS
Neurelis Inc
NeuroAdjuvants Inc
Neurocrine Biosciences Inc
Neuroene Therapeutics LLC
Neurona Therapeutics Inc
New Amsterdam Sciences Inc
Nissan Chemical Corp
Noema Pharma AG
NoNO Inc
NuBioPharma LLC
OB Pharmaceuticals
OMass Therapeutics Limited
Oncocross Co Ltd
Otsuka Pharmaceutical Co Ltd
Ovid Therapeutics Inc
OWP Pharmaceuticals Inc
Panaxia Pharmaceutical Industries Ltd
Pfizer Inc
PharmaTher Holdings Ltd
PharmatrophiX Inc
PIQUR Therapeutics AG
Praxis Precision Medicines Inc
Primetime Life Sciences LLC
Promius Pharma LLC
Proniras Corp
Protheragen Inc
Proveca Ltd
PTC Therapeutics Inc
Puretech Health Plc
Q-State Biosciences Inc
Reata Pharmaceuticals Inc
reMYND NV
RespireRx Pharmaceuticals Inc
RogCon Inc
Sage Therapeutics Inc
Saniona AB
Scientus Pharma Inc
SciSparc Ltd
Serina Therapeutics Inc
Shackelford Pharma Inc
Shanghai Lvdao Pharmaceutical Technology Co Ltd
Shanghai Zhimeng Biopharma Inc
Simcere Pharmaceutical Group Ltd
SK Biopharmaceuticals Co Ltd
SK Chemicals Co Ltd
Skye Bioscience Inc
SoVarGen Co Ltd
Spark Therapeutics Inc
Stoke Therapeutics Inc
StrideBio Inc
Sumitomo Dainippon Pharma Co Ltd
Sun Pharma Advanced Research Company Ltd
Supernus Pharmaceuticals Inc
Sustained Nano Systems LLC
Taho Pharmaceuticals Ltd
Takeda Pharmaceutical Co Ltd
Tavanta Therapeutics Inc
Taysha Gene Therapies Inc
Techfields Pharma Co Ltd
Tevard Biosciences LLC
The Cell Factory BVBA
Trevena Inc
UCB SA
Ultragenyx Pharmaceutical Inc
Viatris Inc
Virpax Pharmaceuticals Inc
VistaGen Therapeutics Inc
Vitality Biopharma Inc
Vyripharm Biopharmaceuticals
Whan In Pharm Co Ltd
Xenon Pharmaceuticals Inc
Xeris Biopharma Holdings Inc
XPhyto Therapeutics Corp
XWPharma Ltd
Zhejiang Conba Pharmaceutical Co Ltd
Zogenix Inc
Zynerba Pharmaceuticals Inc
Table of Contents
644 Pages
- Introduction
- Global Markets Direct Report Coverage
- Epilepsy - Overview
- Epilepsy - Therapeutics Development
- Pipeline Overview
- Pipeline by Companies
- Pipeline by Universities/Institutes
- Products under Development by Companies
- Products under Development by Universities/Institutes
- Epilepsy - Therapeutics Assessment
- Assessment by Target
- Assessment by Mechanism of Action
- Assessment by Route of Administration
- Assessment by Molecule Type
- Epilepsy - Companies Involved in Therapeutics Development
- Epilepsy - Drug Profiles
- Epilepsy - Dormant Projects
- Epilepsy - Discontinued Products
- Epilepsy - Product Development Milestones
- Featured News & Press Releases
- Appendix
- Methodology
- Coverage
- Secondary Research
- Primary Research
- Expert Panel Validation
- Contact Us
- Disclaimer
- List of Tables
- Number of Products under Development for Epilepsy, 2022
- Number of Products under Development by Companies, 2022
- Number of Products under Development by Companies, 2022 (Contd..1)
- Number of Products under Development by Companies, 2022 (Contd..2)
- Number of Products under Development by Companies, 2022 (Contd..3)
- Number of Products under Development by Companies, 2022 (Contd..4)
- Number of Products under Development by Companies, 2022 (Contd..5)
- Number of Products under Development by Companies, 2022 (Contd..6)
- Number of Products under Development by Companies, 2022 (Contd..7)
- Number of Products under Development by Companies, 2022 (Contd..8)
- Number of Products under Development by Universities/Institutes, 2022
- Products under Development by Companies, 2022
- Products under Development by Companies, 2022 (Contd..1)
- Products under Development by Companies, 2022 (Contd..2)
- Products under Development by Companies, 2022 (Contd..3)
- Products under Development by Companies, 2022 (Contd..4)
- Products under Development by Companies, 2022 (Contd..5)
- Products under Development by Companies, 2022 (Contd..6)
- Products under Development by Companies, 2022 (Contd..7)
- Products under Development by Companies, 2022 (Contd..8)
- Products under Development by Companies, 2022 (Contd..9)
- Products under Development by Companies, 2022 (Contd..10)
- Products under Development by Companies, 2022 (Contd..11)
- Products under Development by Companies, 2022 (Contd..12)
- Products under Development by Companies, 2022 (Contd..13)
- Products under Development by Companies, 2022 (Contd..14)
- Products under Development by Companies, 2022 (Contd..15)
- Products under Development by Companies, 2022 (Contd..16)
- Products under Development by Companies, 2022 (Contd..17)
- Products under Development by Companies, 2022 (Contd..18)
- Products under Development by Universities/Institutes, 2022
- Products under Development by Universities/Institutes, 2022 (Contd..1)
- Number of Products by Stage and Target, 2022
- Number of Products by Stage and Target, 2022 (Contd..1)
- Number of Products by Stage and Target, 2022 (Contd..2)
- Number of Products by Stage and Target, 2022 (Contd..3)
- Number of Products by Stage and Target, 2022 (Contd..4)
- Number of Products by Stage and Mechanism of Action, 2022
- Number of Products by Stage and Mechanism of Action, 2022 (Contd..1)
- Number of Products by Stage and Mechanism of Action, 2022 (Contd..2)
- Number of Products by Stage and Mechanism of Action, 2022 (Contd..3)
- Number of Products by Stage and Mechanism of Action, 2022 (Contd..4)
- Number of Products by Stage and Route of Administration, 2022
- Number of Products by Stage and Molecule Type, 2022
- Epilepsy - Pipeline by a:head Bio AG, 2022
- Epilepsy - Pipeline by Aadi Bioscience Inc, 2022
- Epilepsy - Pipeline by Accure Therapeutics SL, 2022
- Epilepsy - Pipeline by Advanced Neural Dynamics Inc, 2022
- Epilepsy - Pipeline by Advicenne SA, 2022
- Epilepsy - Pipeline by Aequus Pharmaceuticals Inc, 2022
- Epilepsy - Pipeline by AfaSci Inc, 2022
- Epilepsy - Pipeline by Affectis Pharmaceuticals AG, 2022
- Epilepsy - Pipeline by AgoneX Biopharmaceuticals Inc, 2022
- Epilepsy - Pipeline by Altamira Therapeutics Ltd, 2022
- Epilepsy - Pipeline by AMO Pharma Ltd, 2022
- Epilepsy - Pipeline by Anavex Life Sciences Corp, 2022
- Epilepsy - Pipeline by Aphios Corp, 2022
- Epilepsy - Pipeline by Apteeus SAS, 2022
- Epilepsy - Pipeline by Aquestive Therapeutics Inc, 2022
- Epilepsy - Pipeline by Arovella Therapeutics Ltd, 2022
- Epilepsy - Pipeline by Aucta Pharmaceuticals LLC, 2022
- Epilepsy - Pipeline by Aurum Biosciences Ltd, 2022
- Epilepsy - Pipeline by Avicanna Inc, 2022
- Epilepsy - Pipeline by Azurity Pharmaceuticals Inc, 2022
- Epilepsy - Pipeline by B&A Therapeutics, 2022
- Epilepsy - Pipeline by Baergic Bio Inc, 2022
- Epilepsy - Pipeline by BCWorld Pharm Co Ltd, 2022
- Epilepsy - Pipeline by Bio-Pharm Solutions Co Ltd, 2022
- Epilepsy - Pipeline by Bioasis Technologies Inc, 2022
- Epilepsy - Pipeline by Bioinnotis, 2022
- Epilepsy - Pipeline by Biom Therapeutics LLC, 2022
- Epilepsy - Pipeline by Biorchestra Co Ltd, 2022
- Epilepsy - Pipeline by Biovista Inc, 2022
- Epilepsy - Pipeline by Bloom Science Inc, 2022
- Epilepsy - Pipeline by Bright Minds Biosciences Inc, 2022
- Epilepsy - Pipeline by Bristol-Myers Squibb Co, 2022
- Epilepsy - Pipeline by CAMP4 Therapeutics Corp, 2022
- Epilepsy - Pipeline by Cann Pharmaceutical Australia Ltd, 2022
- Epilepsy - Pipeline by Cavion LLC, 2022
- Epilepsy - Pipeline by Celavie Biosciences LLC, 2022
- Epilepsy - Pipeline by Cellix Bio Pvt Ltd, 2022
- Epilepsy - Pipeline by Cerebral Therapeutics Inc, 2022
- Epilepsy - Pipeline by Cerecin Pte Ltd, 2022
- Epilepsy - Pipeline by Cerevel Therapeutics Holdings Inc, 2022
- Epilepsy - Pipeline by Coda Biotherapeutics Inc, 2022
- Epilepsy - Pipeline by Corestem Inc, 2022
- Epilepsy - Pipeline by Corlieve Therapeutics SAS, 2022
- Epilepsy - Pipeline by Crossject SA, 2022
- Epilepsy - Pipeline by CSL Ltd, 2022
- Epilepsy - Pipeline by Cure Pharmaceutical Holding Corp, 2022
- Epilepsy - Pipeline by CuroNZ Ltd, 2022
- Epilepsy - Pipeline by CURx Pharmaceuticals Inc, 2022
- Epilepsy - Pipeline by Cypralis Ltd, 2022
- Epilepsy - Pipeline by Eisai Co Ltd, 2022
- Epilepsy - Pipeline by Eliem Therapeutics Inc, 2022
- Epilepsy - Pipeline by Encoded Therapeutics Inc, 2022
- Epilepsy - Pipeline by Engrail Therapeutics Inc, 2022
- Epilepsy - Pipeline by Epalex Corp, 2022
- Epilepsy - Pipeline by EpyGenix Therapeutics Inc, 2022
- Epilepsy - Pipeline by Equilibre Biopharmaceuticals Corp, 2022
- Epilepsy - Pipeline by ES Therapeutics LLC, 2022
- Epilepsy - Pipeline by Eton Pharmaceuticals Inc, 2022
- Epilepsy - Pipeline by Ferring Pharmaceuticals Inc, 2022
- Epilepsy - Pipeline by GABA Therapeutics Inc, 2022
- Epilepsy - Pipeline by GAOMA Therapeutics, 2022
- Epilepsy - Pipeline by Gene Therapy Research Institution Co Ltd, 2022
- Epilepsy - Pipeline by GenEp Inc, 2022
- Epilepsy - Pipeline by Genochem SAS, 2022
- Epilepsy - Pipeline by Genus Lifesciences Inc, 2022
- Epilepsy - Pipeline by Guangzhou Cellprotek Pharmaceutical Co Ltd, 2022
- Epilepsy - Pipeline by H. Lundbeck AS, 2022
- Epilepsy - Pipeline by Harbin Pharmaceutical Group Co Ltd, 2022
- Epilepsy - Pipeline by Herophilus, 2022
- Epilepsy - Pipeline by ImmunoChem Therapeutics LLC, 2022
- Epilepsy - Pipeline by InteRNA Technologies BV, 2022
- Epilepsy - Pipeline by Ionis Pharmaceuticals Inc, 2022
- Epilepsy - Pipeline by Iproteos SL, 2022
- Epilepsy - Pipeline by iQure Pharma Inc, 2022
- Epilepsy - Pipeline by Jazz Pharmaceuticals Plc, 2022
- Epilepsy - Pipeline by JC Pharma Inc, 2022
- Epilepsy - Pipeline by Johnson & Johnson, 2022
- Epilepsy - Pipeline by Ketogen Inc, 2022
- Epilepsy - Pipeline by Klaria Pharma Holding AB, 2022
- Epilepsy - Pipeline by Knopp Biosciences LLC, 2022
- Epilepsy - Pipeline by LATITUDE Pharmaceuticals Inc, 2022
- Epilepsy - Pipeline by Lead Discovery Center GmbH, 2022
- Epilepsy - Pipeline by Lexaria Bioscience Corp, 2022
- Epilepsy - Pipeline by LifeSplice Pharma LLC, 2022
- Epilepsy - Pipeline by Lipocine Inc, 2022
- Epilepsy - Pipeline by Longboard Pharmaceuticals Inc, 2022
- Epilepsy - Pipeline by Luminus Biosciences Inc, 2022
- Epilepsy - Pipeline by Marinus Pharmaceuticals Inc, 2022
- Epilepsy - Pipeline by Medicure Inc, 2022
- Epilepsy - Pipeline by Mediphage Bioceuticals Inc, 2022
- Epilepsy - Pipeline by Medlab Clinical Ltd, 2022
- Epilepsy - Pipeline by Mercaptor Discoveries Inc, 2022
- Epilepsy - Pipeline by Metys Pharmaceuticals AG, 2022
- Epilepsy - Pipeline by MGC Pharmaceuticals Ltd, 2022
- Epilepsy - Pipeline by Mucodel Pharma LLC, 2022
- Epilepsy - Pipeline by MyMD Pharmaceuticals, Inc, 2022
- Epilepsy - Pipeline by MyX Therapeutics Inc, 2022
- Epilepsy - Pipeline by Nasus Pharma Ltd, 2022
- Epilepsy - Pipeline by Navega Therapeutics Inc, 2022
- Epilepsy - Pipeline by Navitor Pharmaceuticals Inc, 2022
- Epilepsy - Pipeline by Neonc Technologies Inc, 2022
- Epilepsy - Pipeline by NeuCyte Inc, 2022
- Epilepsy - Pipeline by NeuExcell Therapeutics Inc, 2022
- Epilepsy - Pipeline by NeurAegis Inc, 2022
- Epilepsy - Pipeline by Neuraxpharm France SAS, 2022
- Epilepsy - Pipeline by Neurelis Inc, 2022
- Epilepsy - Pipeline by NeuroAdjuvants Inc, 2022
- Epilepsy - Pipeline by Neurocrine Biosciences Inc, 2022
- Epilepsy - Pipeline by Neuroene Therapeutics LLC, 2022
- Epilepsy - Pipeline by Neurona Therapeutics Inc, 2022
- Epilepsy - Pipeline by New Amsterdam Sciences Inc, 2022
- Epilepsy - Pipeline by Nissan Chemical Corp, 2022
- Epilepsy - Pipeline by Noema Pharma AG, 2022
- Epilepsy - Pipeline by NoNO Inc, 2022
- Epilepsy - Pipeline by NuBioPharma LLC, 2022
- Epilepsy - Pipeline by OB Pharmaceuticals, 2022
- Epilepsy - Pipeline by OMass Therapeutics Limited, 2022
- Epilepsy - Pipeline by Oncocross Co Ltd, 2022
- Epilepsy - Pipeline by Otsuka Pharmaceutical Co Ltd, 2022
- Epilepsy - Pipeline by Ovid Therapeutics Inc, 2022
- Epilepsy - Pipeline by OWP Pharmaceuticals Inc, 2022
- Epilepsy - Pipeline by Panaxia Pharmaceutical Industries Ltd, 2022
- Epilepsy - Pipeline by Pfizer Inc, 2022
- Epilepsy - Pipeline by PharmaTher Holdings Ltd, 2022
- Epilepsy - Pipeline by PharmatrophiX Inc, 2022
- Epilepsy - Pipeline by PIQUR Therapeutics AG, 2022
- Epilepsy - Pipeline by Praxis Precision Medicines Inc, 2022
- Epilepsy - Pipeline by Primetime Life Sciences LLC, 2022
- Epilepsy - Pipeline by Promius Pharma LLC, 2022
- Epilepsy - Pipeline by Proniras Corp, 2022
- Epilepsy - Pipeline by Protheragen Inc, 2022
- Epilepsy - Pipeline by Proveca Ltd, 2022
- Epilepsy - Pipeline by PTC Therapeutics Inc, 2022
- Epilepsy - Pipeline by Puretech Health Plc, 2022
- Epilepsy - Pipeline by Q-State Biosciences Inc, 2022
- Epilepsy - Pipeline by Reata Pharmaceuticals Inc, 2022
- Epilepsy - Pipeline by reMYND NV, 2022
- Epilepsy - Pipeline by RespireRx Pharmaceuticals Inc, 2022
- Epilepsy - Pipeline by RogCon Inc, 2022
- Epilepsy - Pipeline by Sage Therapeutics Inc, 2022
- Epilepsy - Pipeline by Saniona AB, 2022
- Epilepsy - Pipeline by Scientus Pharma Inc, 2022
- Epilepsy - Pipeline by SciSparc Ltd, 2022
- Epilepsy - Pipeline by Serina Therapeutics Inc, 2022
- Epilepsy - Pipeline by Shackelford Pharma Inc, 2022
- Epilepsy - Pipeline by Shanghai Lvdao Pharmaceutical Technology Co Ltd, 2022
- Epilepsy - Pipeline by Shanghai Zhimeng Biopharma Inc, 2022
- Epilepsy - Pipeline by Simcere Pharmaceutical Group Ltd, 2022
- Epilepsy - Pipeline by SK Biopharmaceuticals Co Ltd, 2022
- Epilepsy - Pipeline by SK Chemicals Co Ltd, 2022
- Epilepsy - Pipeline by Skye Bioscience Inc, 2022
- Epilepsy - Pipeline by SoVarGen Co Ltd, 2022
- Epilepsy - Pipeline by Spark Therapeutics Inc, 2022
- Epilepsy - Pipeline by Stoke Therapeutics Inc, 2022
- Epilepsy - Pipeline by StrideBio Inc, 2022
- Epilepsy - Pipeline by Sumitomo Dainippon Pharma Co Ltd, 2022
- Epilepsy - Pipeline by Sun Pharma Advanced Research Company Ltd, 2022
- Epilepsy - Pipeline by Supernus Pharmaceuticals Inc, 2022
- Epilepsy - Pipeline by Sustained Nano Systems LLC, 2022
- Epilepsy - Pipeline by Taho Pharmaceuticals Ltd, 2022
- Epilepsy - Pipeline by Takeda Pharmaceutical Co Ltd, 2022
- Epilepsy - Pipeline by Tavanta Therapeutics Inc, 2022
- Epilepsy - Pipeline by Taysha Gene Therapies Inc, 2022
- Epilepsy - Pipeline by Techfields Pharma Co Ltd, 2022
- Epilepsy - Pipeline by Tevard Biosciences LLC, 2022
- Epilepsy - Pipeline by The Cell Factory BVBA, 2022
- Epilepsy - Pipeline by Trevena Inc, 2022
- Epilepsy - Pipeline by UCB SA, 2022
- Epilepsy - Pipeline by Ultragenyx Pharmaceutical Inc, 2022
- Epilepsy - Pipeline by Viatris Inc, 2022
- Epilepsy - Pipeline by Virpax Pharmaceuticals Inc, 2022
- Epilepsy - Pipeline by VistaGen Therapeutics Inc, 2022
- Epilepsy - Pipeline by Vitality Biopharma Inc, 2022
- Epilepsy - Pipeline by Vyripharm Biopharmaceuticals, 2022
- Epilepsy - Pipeline by Whan In Pharm Co Ltd, 2022
- Epilepsy - Pipeline by Xenon Pharmaceuticals Inc, 2022
- Epilepsy - Pipeline by Xeris Biopharma Holdings Inc, 2022
- Epilepsy - Pipeline by XPhyto Therapeutics Corp, 2022
- Epilepsy - Pipeline by XWPharma Ltd, 2022
- Epilepsy - Pipeline by Zhejiang Conba Pharmaceutical Co Ltd, 2022
- Epilepsy - Pipeline by Zogenix Inc, 2022
- Epilepsy - Pipeline by Zynerba Pharmaceuticals Inc, 2022
- Epilepsy - Dormant Projects, 2022
- Epilepsy - Discontinued Products, 2022
- Epilepsy - Discontinued Products, 2022 (Contd..1)
- List of Figures
- Number of Products under Development for Epilepsy, 2022
- Number of Products under Development by Companies, 2022
- Number of Products under Development by Universities/Institutes, 2022
- Number of Products by Top 10 Targets, 2022
- Number of Products by Stage and Top 10 Targets, 2022
- Number of Products by Top 10 Mechanism of Actions, 2022
- Number of Products by Stage and Top 10 Mechanism of Actions, 2022
- Number of Products by Top 10 Routes of Administration, 2022
- Number of Products by Stage and Top 10 Routes of Administration, 2022
- Number of Products by Top 10 Molecule Types, 2022
- Number of Products by Stage and Top 10 Molecule Types, 2022
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
